Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yee Sin Leo

Showing results (301-310 of 328) with videos related to

Pageof 33
Sort By:
Cell Reports. Medicine|January 26, 2021
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19Yun Shan Goh, Jean-Marc Chavatte, Alicia Lim Jieling, et al.
Ebiomedicine|July 26, 2020
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severitySiti Naqiah Amrun, Cheryl Yi-Pin Lee, Bernett Lee, et al.
Clinical & Translational Immunology|February 25, 2021
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variantCheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, et al.
Scientific Reports|November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
Journal of Clinical Immunology|October 30, 2021
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant InfectionSiew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, et al.
Ebiomedicine|April 12, 2021
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational studyBarnaby E Young, Wycliffe E Wei, Siew-Wai Fong, et al.
Science Translational Medicine|June 23, 2012
The structural basis for serotype-specific neutralization of dengue virus by a human antibodyEe Ping Teoh, Petra Kukkaro, En Wei Teo, et al.
EMBO Molecular Medicine|May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
Frontiers in Immunology|July 19, 2023
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBBZi Wei Chang, Yun Shan Goh, Angeline Rouers, et al.
Frontiers in Immunology|December 1, 2022
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individualsYun Shan Goh, Angeline Rouers, Siew-Wai Fong, et al.
Pageof 33

Showing results (301-310 of 328) with videos related to

Sort By:
Pageof 33
Cell Reports. Medicine|January 26, 2021
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic individuals with COVID-19Yun Shan Goh, Jean-Marc Chavatte, Alicia Lim Jieling, et al.
Ebiomedicine|July 26, 2020
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severitySiti Naqiah Amrun, Cheryl Yi-Pin Lee, Bernett Lee, et al.
Clinical & Translational Immunology|February 25, 2021
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variantCheryl Yi-Pin Lee, Siti Naqiah Amrun, Rhonda Sin-Ling Chee, et al.
Scientific Reports|November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
Journal of Clinical Immunology|October 30, 2021
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant InfectionSiew-Wai Fong, Nicholas Kim-Wah Yeo, Yi-Hao Chan, et al.
Ebiomedicine|April 12, 2021
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational studyBarnaby E Young, Wycliffe E Wei, Siew-Wai Fong, et al.
Science Translational Medicine|June 23, 2012
The structural basis for serotype-specific neutralization of dengue virus by a human antibodyEe Ping Teoh, Petra Kukkaro, En Wei Teo, et al.
EMBO Molecular Medicine|May 7, 2021
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, et al.
Frontiers in Immunology|July 19, 2023
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBBZi Wei Chang, Yun Shan Goh, Angeline Rouers, et al.
Frontiers in Immunology|December 1, 2022
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individualsYun Shan Goh, Angeline Rouers, Siew-Wai Fong, et al.
Pageof 33